Maura McCarthy has two decades of experience in oncology drug and diagnostic development, clinical research, health policy, advocacy and communications, and business development. Driven by the intersection of business and global public health, Maura brings diverse perspectives from biotechnology, government, philanthropic, and non-governmental organizations to the development of women’s cancer programs. As Senior Technical Advisor

Anne Hyre is a certified nurse-midwife with more than 25 years of experience in innovative program design, strategic planning, management and research/evaluation related to quality improvement of maternal, newborn and reproductive health services. She has served as chief of party and country director, worked in 20 countries around the globe and lived in low- and

Naoko Doi has over 20 years of private sector and public health experience in strategic planning, policy development, program design and implementation, community engagement and market shaping for infectious disease programs in resource-limited settings. Her work has focused on increasing access to priority therapeutics, diagnostic products, enabling technologies and service delivery innovations that enable the